NASDAQ

Embecta Corp. (EMBC)

491 Thanks from members

Embecta Corp. (EMBC) experiences extreme volatility, marked by a disastrous Q2 2026 guidance cut and revenue drop followed by a sequential Q3 earnings beat, though long-term pressures from BD spin-off debt, U.S. volume headwinds, and GLP-1 adoption persist.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →